PT Pyridam Farma Tbk (PYFA.JK)
IDR 208.0
(-3.7%)
IDR 208.0
(-3.7%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 897.02 Billion IDR | 15.98% |
| 2022 | 773.45 Billion IDR | 92.84% |
| 2021 | 401.08 Billion IDR | 1449.96% |
| 2020 | 25.87 Billion IDR | 83.33% |
| 2019 | 14.11 Billion IDR | -37.46% |
| 2018 | 22.56 Billion IDR | 128.25% |
| 2017 | 9.88 Billion IDR | -62.5% |
| 2016 | 26.36 Billion IDR | -11.42% |
| 2015 | 29.76 Billion IDR | -33.44% |
| 2014 | 44.71 Billion IDR | 3.91% |
| 2013 | 43.03 Billion IDR | 75.72% |
| 2012 | 24.48 Billion IDR | 112.25% |
| 2011 | 11.53 Billion IDR | 132.12% |
| 2010 | 4.97 Billion IDR | -60.38% |
| 2009 | 12.54 Billion IDR | -14.92% |
| 2008 | 14.74 Billion IDR | 3.21% |
| 2007 | 14.28 Billion IDR | 21.43% |
| 2006 | 11.76 Billion IDR | 53.56% |
| 2005 | 7.66 Billion IDR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 943.79 Billion IDR | 5.21% |
| 2024 Q3 | 1294.5 Billion IDR | 1.05% |
| 2024 Q2 | 3342.51 Billion IDR | 254.16% |
| 2023 Q4 | 897.02 Billion IDR | 3.58% |
| 2023 Q1 | 789.04 Billion IDR | 2.02% |
| 2023 Q2 | 834.72 Billion IDR | 5.79% |
| 2023 FY | 897.02 Billion IDR | 15.98% |
| 2023 Q3 | 866.04 Billion IDR | 3.75% |
| 2022 Q2 | 533.1 Billion IDR | 16.38% |
| 2022 FY | 773.45 Billion IDR | 92.84% |
| 2022 Q4 | 773.45 Billion IDR | -0.39% |
| 2022 Q1 | 458.06 Billion IDR | 14.21% |
| 2022 Q3 | 776.5 Billion IDR | 45.66% |
| 2021 Q3 | 305.66 Billion IDR | -3.95% |
| 2021 Q2 | 318.24 Billion IDR | 4.69% |
| 2021 Q1 | 304 Billion IDR | 1074.81% |
| 2021 FY | 401.08 Billion IDR | 1449.96% |
| 2021 Q4 | 401.08 Billion IDR | 31.22% |
| 2020 Q1 | 14.79 Billion IDR | 4.81% |
| 2020 FY | 25.87 Billion IDR | 83.33% |
| 2020 Q4 | 25.87 Billion IDR | 36.47% |
| 2020 Q3 | 18.96 Billion IDR | 62.91% |
| 2020 Q2 | 11.63 Billion IDR | -21.33% |
| 2019 Q3 | 21.23 Billion IDR | -10.71% |
| 2019 Q4 | 14.11 Billion IDR | -33.53% |
| 2019 Q2 | 23.78 Billion IDR | -3.48% |
| 2019 FY | 14.11 Billion IDR | -37.46% |
| 2019 Q1 | 24.64 Billion IDR | 9.19% |
| 2018 Q1 | 26.33 Billion IDR | 166.35% |
| 2018 FY | 22.56 Billion IDR | 128.25% |
| 2018 Q4 | 22.56 Billion IDR | -24.65% |
| 2018 Q3 | 29.95 Billion IDR | -7.25% |
| 2018 Q2 | 32.29 Billion IDR | 22.63% |
| 2017 FY | 9.88 Billion IDR | -62.5% |
| 2017 Q2 | 27.21 Billion IDR | -7.01% |
| 2017 Q1 | 29.26 Billion IDR | 11.0% |
| 2017 Q3 | 16.11 Billion IDR | -40.79% |
| 2017 Q4 | 9.88 Billion IDR | -38.64% |
| 2016 Q3 | 22.66 Billion IDR | -18.13% |
| 2016 Q1 | 25.13 Billion IDR | -15.55% |
| 2016 FY | 26.36 Billion IDR | -11.42% |
| 2016 Q4 | 26.36 Billion IDR | 16.3% |
| 2016 Q2 | 27.68 Billion IDR | 10.16% |
| 2015 Q3 | 38.88 Billion IDR | -1.49% |
| 2015 FY | 29.76 Billion IDR | -33.44% |
| 2015 Q1 | 41.29 Billion IDR | -7.66% |
| 2015 Q2 | 39.46 Billion IDR | -4.41% |
| 2015 Q4 | 29.76 Billion IDR | -23.46% |
| 2014 Q4 | 44.71 Billion IDR | -3.37% |
| 2014 FY | 44.71 Billion IDR | 3.91% |
| 2014 Q3 | 46.27 Billion IDR | -1.77% |
| 2014 Q2 | 47.1 Billion IDR | 2.76% |
| 2014 Q1 | 45.84 Billion IDR | 6.53% |
| 2013 FY | 43.03 Billion IDR | 75.72% |
| 2013 Q2 | 46.35 Billion IDR | 84.62% |
| 2013 Q3 | 48.32 Billion IDR | 4.25% |
| 2013 Q4 | 43.03 Billion IDR | -10.95% |
| 2013 Q1 | 25.1 Billion IDR | 2.53% |
| 2012 Q1 | 9.15 Billion IDR | -20.69% |
| 2012 FY | 24.48 Billion IDR | 112.25% |
| 2012 Q2 | 15.79 Billion IDR | 72.56% |
| 2012 Q3 | 23.37 Billion IDR | 48.05% |
| 2012 Q4 | 24.48 Billion IDR | 4.76% |
| 2011 Q4 | 11.53 Billion IDR | 0.0% |
| 2011 FY | 11.53 Billion IDR | 132.12% |
| 2010 FY | 4.97 Billion IDR | -60.38% |
| 2009 FY | 12.54 Billion IDR | -14.92% |
| 2008 FY | 14.74 Billion IDR | 3.21% |
| 2007 FY | 14.28 Billion IDR | 21.43% |
| 2006 FY | 11.76 Billion IDR | 53.56% |
| 2005 FY | 7.66 Billion IDR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | -238.56 Billion IDR | 476.001% |
| PT Merck Tbk | -183.3 Billion IDR | 589.362% |
| PT Phapros, Tbk | 736.73 Billion IDR | -21.756% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | -820.73 Billion IDR | 209.295% |
| PT Tempo Scan Pacific Tbk | -2577.85 Billion IDR | 134.797% |